Detoxication (phase 2) enzymes, such as glutathione S-transferases (GSTs), NAD(P)H:(quinone-acceptor) The upstream enhancer elements of the mouse and rat liver glutathione transferase Ya genes that respond to these inducers are nearly identical 41-bp segments and have been termed the electrophile-responsive element (EpRE) (5) and the antioxidant-responsive element (ARE) (6), respectivelyt; the mouse and rat 41-bp segments differ at only two sites-bases 1 and 14 are G in the rat segment, leaving it with only one ARE instead of the two AREs in the mouse segment.
glucuronosyltransferases (1) (2) (3) . These widely distributed enzymes detoxify electrophiles, thereby protecting cells against the toxic and neoplastic effects of carcinogens. Understanding the chemistry and molecular mechanisms of these inductions is therefore of primary importance in devising strategies for chemoprotection against cancer. (For definitions of phase 1 and phase 2 enzymes and of bifunctional and monofunctional inducers, see ref. 4 .)
The upstream enhancer elements of the mouse and rat liver glutathione transferase Ya genes that respond to these inducers are nearly identical 41-bp segments and have been termed the electrophile-responsive element (EpRE) (5) and the antioxidant-responsive element (ARE) (6) , respectivelyt; the mouse and rat 41-bp segments differ at only two sites-bases 1 and 14 are G in the rat segment, leaving it with only one ARE instead of the two AREs in the mouse segment.
The critical DNA sequences of the EpRE that respond to monofunctional inducers (labeled ARE in Fig. 1B ) have been presumed to resemble AP-1-binding sites; AP-1 constitutes a family of transcription-activating DNA-binding proteins that bind to phorbol 12-tetradecanoate 13-acetate (TPA)-responsive elements (TREs) (7) . Similar sequences have also been identified in the upstream regions of the human and rat QR genes (8) (9) (10) (11) and the heavy subunit of the human y-glutamylcysteine synthetase gene (12) .
Apparently, all monofunctional phase 2 enzyme inducers increase phase 2 gene transcription via their upstream EpRE/ ARE elements (2, 3, 5, 6, 13, 14) ,. hut the identity of the EpRE/ARE enhancer-binding protein(s) is controversial. Daniel We have previously demonstrated that at least eight distinct classes of inducers act via the mouse EpRE/ARE site. Recently, it has been shown that one compound (TBHQ) from these classes specifically stimulates rat ARE (13) and mouse EpRE (20) sequences but fails to activate a TRE site (20) or a rat ARE sequence that had been changed to TRE (13 (Fig. 1B) , have been described (2) . pTRE-284YaGH was made by directly ligating the oligonucleotide 5'-agc TAA TGA CTC ATT g-3' and its complement 5'-tcg acAATG AGT CAT T-3' (TRE, Fig. 1B 
RESULTS AND DISCUSSION
Induction of Quinone Reductase in F9 Cells. Since undifferentiated murine F9 embryonal carcinoma cells do not express endogenous TRE binding activity (27) (28) (29) , these cells are valuable in elucidating the mechanism of phase 2 enzyme induction. Extensive experiments with Hepa lclc7 cells (25, (30) (31) (32) (33) showed that QR induction is a useful indicator of overall phase 2 enzyme induction. The basal specific activity of QR in undifferentiated F9 cells [697 nmol/min per mg; CV, 10.5%; means of two separate experiments, n = 4 per experiment] was significantly higher than that of Hepa lclc7 cells (208 nmol/min per mg) (25) . Fig. 2 shows that exposure of F9 cells to compounds 1, 3, 5, and 6 ( Fig. 3) gave significant, concentration-dependent inductions of QR. These results strongly suggest that induction of QR does not involve TRE function, unless the inducers cause the accumulation of AP-1 proteins in these cells (see below).
Induction of the EpRE Enhancer Transfected into F9 Cells.
When F9 cells were transfected with the p41-284YaGH plasmid (containing the 41-bp EpRE sequence from the murine GST Ya gene and its homologous promoter), significant and dose-dependent GH production was induced by several compounds (compounds 1-9 in Fig. 3 ) known to be inducers of QR in Hepa lclc7 cells. No GH response was observed with two related compounds (10, 11) inactive in the Hepa 1c1c7 system (Fig. 4) . As expected, TPA was inactive in these transfected F9 cells (20) . Basal GH secretion was 0.345 ng/ml (CV, 12%; n = 5). In a repeat experiment, basal activity was 0.535 ng/ml (CV, 11%; n = 5). For comparison, basal GH secretion by F9 cells containing the enhancerless plasmid p284YaGH was 0.13 ng/ml (CV, 22%; n = 5), which was barely detectable and comparable to the secretion (0.1 ng/ml, detection limit) of untransfected F9 cells. It was possible that activation of the EpRE in F9 cells was due to accumulation of TRE-binding proteins. Friling et al. (7) observed 3-fold induction of chloramphenicol acetyltransferase activity by TBHQ driven by the EpRE enhancer in F9 cells and suggested that this might be due to induction of c-Fos 3 . Structures: 1, TBHQ; 2, 1,2-dithiole-3-thione; 3, sulforaphane; 4, sodium arsenite; 5, trans-4-phenylbut-3-en-2-one; 6, 2,3-dimercapto-1-propanol; 7, mercury(II) chloride; 8, 1-nitro-1-cyclohexene; 9, 5,6-dihydro-2H-pyran-2-one; 10, resorcinol; 11, 2H-pyran-2-one; 12, phenylarsine oxide.
and Jun-B proteins in response to TPA treatment, as observed by Chiu et al. (34) . Furthermore, when c-Fos and c-Jun were overexpressed in F9 cells by transfection, cotransfected EpRE sequences were activated (7). Various chemical treatments can induce differentiation of F9 cells (27, 35, 36) and the expression of various enhancer binding proteins. Hence we transfected F9 cells with the construct pTRE-284YaGH in which the 41-bp EpRE is replaced by a consensus TRE site (Fig. iB) . Cells were then treated with compounds 1-12 and with TPA over a range of concentrations. In no case was any induction observed (data not shown), although we detected low basal GH secretion (0.19 ng/ml; CV, 17%; n = 5). Transfection was confirmed by detection of luciferase activity when cells were also transfected with pGL3-Control. When pTRE-284YaGH was transfected into Hep G2 cells, however, TPA treatment led to a large induction of GH reporter gene expression (discussed below), showing that this construct is functional and can respond to TPA in the correct environment. Therefore, it seems unlikely that these cells are expressing TRE-activating proteins under the conditions of this study. These results are consistent with those of Yoshioka et al. (20) , who observed significant stimulation by TBHQ of only the EpRE/ARE but not the TRE.
Comparison of Efficiencies of Inducer Responses of Plasmids pTRE-284YaGH, pTREX2-284YaGH, and p41-284YaGH in Hep G2 and Hepa lclc7 Cells. Friling et al. (7) showed that a single "so-called" TRE sequence was inducible by TBHQ and also demonstrated that AP-1 proteins bind to 6 4 4 .o3 the EpRE. Thus, they concluded that the two "AP-1-like" sites in the EpRE were simply binding sites for AP-1 binding proteins and further concluded that TBHQ and other inducers act via AP-1 proteins. However, they used the sequence ATGACTCAGCA, which includes the 3'-GC bases crucial for ARE inducibility (8, 13) , and hence they were actually testing a combined EpRE/ARE and TRE sequence. These crucial 3'-GC bases are not included in the classical consensus TRE (22, 23) and thus were changed in our study. We compared the responses of the EpRE sequence and two sequences containing either one or two consensus TRE sites to the eight chemical classes of inducers (Fig. 1B) . The three plasmids containing these sequences, pTRE-284YaGH, pTREX2-284YaGH, and p41-284YaGH, were transfected into Hep G2 cells and treated with a range of concentrations of inducers [1] [2] [3] [4] [5] [6] [7] [8] 12 , and TPA (Fig. 5) . Basal GH secretions, expressed as ng of GH secreted per ml of medium in 48 hr, were 3.28 ± 39% for pTRE284YaGH, 8.56 ± 41% for pTREX2-284YaGH, and 8.77 ± 15% for p41-284YaGH (average ± CV of three independent transfections, normalized for cell number by crystal violet staining, each with six intraexperimental replicates). Thus, basal activity is comparable for all three enhancers.
None of the phase 2 enzyme inducers strongly stimulated the consensus TRE constructs (Fig. 5) . No [1] [2] [3] [4] [5] [6] [7] (Fig. 6 ), using concentrations of inducers that provide significant induction of the EpRE reporter construct. For the TREcontaining plasmids, treatment with compounds 1-7 together with TPA had no effect on the inductions produced by TPA alone (Fig. 6 Top) . In contrast, the same experiment with the EpRE/ARE enhancer element produced additive or even synergistic inductions of this enhancer element (Fig. 6 (7)] and by an as-yet-unidentified EpRE/ARE-specific protein(s) that mediates induction by phase 2 monofunctional enzyme inducers. This might explain why the basal activity of the elements is similar and why both can be induced by TPA, as basal activation and TPA induction may be mediated through proteins capable of activating both sequences. However, the EpRE/ARE-activating protein does not activate the TRE consensus element. Overall, the conclusion that the response to monofunctional phase 2 enzyme inducers is mediated by AP-1 proteins (5, 15, 16, 18, 37) is clearly untenable in light of these and other results (13, 20, 21) . Thus, it is crucial to identify the proteins that specifically interact with the EpRE/ARE sequences and mediate the action of these inducers.
Note Added in Proof. Recently, Xie et al. (38) compared the requirements for inducibility of "ARE" and "TRE" sequences in an effort to define the "response to xenobiotics and antioxidants." These studies involved the use of TPA and of ,-naphthoflavone as inducers. It is unfortunately very difficult to compare our results with those of Xie et al. (38) because these authors used somewhat different definitions of ARE and TRE and not those proposed by the authors who discovered these entities. Furthermore, the only results published for "ARE" inducibility were obtained with a single compound-.3-naphthoflavone-at extremely high concentrations (50 ,uM). ,B-Naphthoflavone is not an antioxidant and is a bifunctional inducer-i.e., it must undergo metabolism to induce phase 2 enzymes.
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